Position in ALNY
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$10,043,564
-$1,712,908 QoQ
Shares Held
33,364
-6.1% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#189
of 780 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026STRS OHIO holds $177,004,891 across 155 Biotechnology names. ALNY ranks #6 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
66,679 | $33,121,459 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
28,557 | $17,806,431 | |
| 3 | MRNA |
Moderna, Inc.
|
209,874 | $14,697,476 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
299,838 | $10,611,266 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
54,428 | $10,193,275 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
33,364 | $10,043,564 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
38,166 | $3,026,182 | |
| 8 | EXEL |
Exelixis, Inc.
|
52,093 | $2,834,380 |
All Filings in ALNY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,043,564 | 33,364 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $11,756,472 | 35,532 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $11,148,515 | 28,036 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $12,761,160 | 27,985 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $9,828,352 | 30,140 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $7,781,166 | 28,817 | Shares | Sole | 2025-05-28 | |
| 2024-12-31 | $5,882,750 | 25,000 | Shares | Sole | 2025-05-28 | |
| 2024-09-30 | $8,104,584 | 29,468 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $6,075,000 | 25,000 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $3,736,250 | 25,000 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $4,785,250 | 25,000 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $4,427,500 | 25,000 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $5,698,200 | 30,000 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $907,048 | 4,528 | Shares | Sole | 2023-08-02 | |
| 2022-12-31 | $861,005 | 3,623 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $662,729 | 3,311 | Shares | Sole | 2022-10-27 | |
| 2022-03-31 | $863,967 | 5,291 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $218,927 | 1,291 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $243,753 | 1,291 | Shares | Sole | 2021-10-22 | |
| 2021-06-30 | $218,850 | 1,291 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $609,940 | 4,320 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $580,965 | 4,470 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $1,680,078 | 11,539 | Shares | Sole | 2020-12-14 | |
| 2020-06-30 | $1,769,618 | 11,948 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $424,732 | 3,902 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||